RadioRx's Series A - IV Round

RadioRx raised a round of funding on April 17, 2013. Investors include InterWest Partners.

RadioRx discovers and develops compounds sourced and adapted from the aerospace industry for treating cancer and other indications. RadioRx’s lead compound is called RRx-001, a structurally unique p…

Articles about RadioRx's Series A - IV Round: